Zurueck zur Suche

Reporte zur Charge 9NH54

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

13Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OR 2 WI 2 MD 1 WA 1 CT 1 ND 1 MI 1 SD 1 IA 1

VAERS 1659116

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9Nh54

moderat
Staat
MD
Alter
62,0
Geschlecht
M
Eingang
31.08.2021
Impfdatum
27.04.2021
Beginn
27.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Mobility decreased Pain in extremity

Symptomtext

Patient presented today 8/31/21 and reported that since getting vaccine he had experienced soreness and pain in arm and limited ROM since vaccine. Has seen ortho, had MRI, intraarticular steroid injection and medrol dose pack taper

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
history of testicular cancer, hyperlipidemia
Andere Medikamente
ascorbic acid (Vitamin C), PO, Daily, 0 Refill(s) 2. aspirin (aspirin 81 mg oral tablet), 81 mg, 1 tab, PO, Daily, 90 tab, 0 Refill(s) 3. cyanocobalamin (Vitamin B12), Daily, 0 Refill(s) 4. ergocalciferol (Vitamin D), PO, Daily, 0 Ref
Allergien
none
Vorherige Impfungen
-

VAERS 1392533

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

moderat
Staat
WI
Alter
56,0
Geschlecht
F
Eingang
11.06.2021
Impfdatum
10.06.2021
Beginn
10.06.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain upper Headache Myalgia Nausea Tremor Vomiting

Symptomtext

Evening after the vaccine: "Last night, out of nowhere, I instantly got a severe headache, muscle aches, felt nauseous, had stomach pain and eventually ended up vomiting. I went and laid down because my body was shaking so much I couldn't control myself. "

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No acute illnesses
Vorgeschichte
Diabetes, HTN, CKD-III, obesity
Andere Medikamente
Lantus 100 UNIT/ML vial solution lisinopril (ZESTRIL) 5 MG tablet chlorthalidone (HYGROTEN) 50 MG tablet atorvastatin (LIPITOR) 20 MG tablet traZODone (DESYREL) 50 MG tablet aspirin 81 MG EC tablet phenazopyridine (Pyridium) 200 MG tablet f
Allergien
Dobutamine
Vorherige Impfungen
-

VAERS 1363736

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

moderat
Staat
WA
Alter
60,0
Geschlecht
F
Eingang
01.06.2021
Impfdatum
01.05.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Back pain Chest pain Discomfort Feeling abnormal Headache Immediate post-injection reaction Injected limb mobility decreased Injection site bruising Injection site discolouration Injection site erythema Injection site pain Injection site reaction Injection site swelling Pain in extremity Screaming

Symptomtext

Needle was put it and burned l ke heck / could not bear the pain / burning and hurting; Her head kind of exploded and that was epic / head was just killing her; Felt really awkward; Arm was throbbing; Arm was throbbing and started screaming; Pain began in her lower back and her arm, head and right side of her hip and moved throughout her body; Area / injected was almost like a baseball sized circle and was read / injection site / turned red; Injection site / the band aid caused a bruise / Injection site is now black all around it; Injection site swelled / continued to swell; Ridiculous to have to use that arm and to lift it like a disabled arm / using that arm was insane; Chest pain; Back pain; Injection site black; This case was reported by a consumer via other manufacturer and described the occurrence of injection site burning in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number 9NH54, expiry date 14th October 2022) for prophylaxis. Concomitant products included TOZINAMERAN (COVID-19 MRNA VACCINE PFIZER) and TOZINAMERAN (COVID-19 MRNA VACCINE PFIZER). On 1st May 2021, the patient received the 1st dose of Shingrix (intramuscular). On 1st May 2021, less than a day after receiving Shingrix, the patient experienced injection site burning, headache, discomfort, pain in arm, screaming, pain, injection site erythema, injection site bruising, injection site swelling, injected limb mobility decreased, chest pain, back pain and injection site discoloration. On an unknown date, the outcome of the injection site burning, headache, discomfort, pain in arm, screaming, pain, injection site erythema, injection site bruising, injection site swelling, injected limb mobility decreased, chest pain, back pain and injection site discoloration were recovered/resolved. It was unknown if the reporter considered the injection site burning, headache, discomfort, pain in arm, screaming, pain, injection site erythema, injection site bruising, injection site swelling, injected limb mobility decreased, chest pain, back pain and injection site discoloration to be related to Shingrix. Additional details were provided as follow: The patient received Shingrix on 1st May 2021 The patient stated that the needle was put in and burned like heck and her head was kind of exploded. The patient wanted to stay in store but felt awkward. The patient stated that her head settled down and her arm was throbbing and she started screaming. The patient stated the pain began in her lower back and her arm, head and right side of her hip and moved throughout her body. The pain rotated out everywhere after 30 minutes the pain settled down and she just had the pain in the arm. The patient stated that the area where vaccine was injected was almost like a baseball sized circle and was red, she removed band aid which caused a bruise and the injection site swelled up and she could not bear the pain. The patient stated that her head was killing her and it was ridiculous to use the arm and lift it like a disabled arm. All the reported events were now recovered/resolved but, the injection site was now black al around it. The reactions lasted for 11 days and sort of calmed down. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
COVID-19 MRNA VACCINE PFIZER; COVID-19 MRNA VACCINE PFIZER
Allergien
-
Vorherige Impfungen
-

VAERS 1296699

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

moderat
Staat
-
Alter
73,0
Geschlecht
F
Eingang
07.05.2021
Impfdatum
04.05.2021
Beginn
04.05.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dehydration Hypersomnia Injection site swelling Pain in extremity

Symptomtext

Patient said after she received the vaccine she went home and slept for 14 hours and woke up very dehydrated. Her arm was also sore and there was swelling at the injections site. She came in on 5/7/21 to report her reactions. She says she feels fine and the swelling and soreness has gone down.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dehydration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1808482

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

mild
Staat
CT
Alter
74,0
Geschlecht
M
Eingang
22.10.2021
Impfdatum
20.10.2021
Beginn
22.10.2021
Tage bis Beginn
2,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Extra dose administered Pyrexia

Symptomtext

Patient received 3 doses of SHINGRIX due to system limitations. First dose received 7/2018, second 12/2018 and third 10/20/21. Computer profile did not go back far enough to see July date. Patient had 101 degree fever the day after the vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
SHINGRIX
Allergien
-
Vorherige Impfungen
-

VAERS 1490727

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

mild
Staat
ND
Alter
65,0
Geschlecht
M
Eingang
21.07.2021
Impfdatum
21.04.2021
Beginn
22.04.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anxiety Depressed mood Headache

Symptomtext

Patient reported that next morning after receiving Shingrix vaccine, he woke up saying that he "had a card game going on in the back of my mind" that lasted the whole day. He said it was extremely distracting and upsetting that it would not stop. He also stated that he became very depressed that morning. He states that he lives alone and became very worried about what he might do. He said that during cancer diagnosis years ago he had some sad times but said this was like nothing he had ever felt before. He was so depressed he called his physician's office. He said that they told him they had never heard of this reaction before and just wait and see what happens. He said that he had a very rough day with the "card game" going on in his head and the very depressed feeling he had. He made it through the day and went to bed. He said the next morning the card game was gone and he had a very bad headache. He still felt depressed but not to the extent of the previous day. He said it took 3-4 days for his mood to go back to normal. He did not report this to the pharmacy until he was told by his physician to go ahead and get his second dose. Upon reporting in great detail what had happened to him and that he was very concerned about getting the next dose, I (pharmacist) advised him to not get the second dose. I told him that even though I had never heard of this before, I was very concerned for his well-being if it happened to him again. He was relieved to be told that it was ok to not have to get the second dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
HX OF CANCER HX OF BLOOD CLOTS HIGH CHOLESTEROL HIGH BLOOD PRESSURE
Andere Medikamente
HYDROCHLOROTHIAZIDE 25MG DAILY -- XARELTO 20MG DAILY -- LISINOPRIL 10MG DAILY -- ROSUVASTATIN 10MG DAILY -- ALBUTEROL HFA INHALER AS NEEDED
Allergien
NONE
Vorherige Impfungen
-

VAERS 1400086

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9nh54

mild
Staat
MI
Alter
61,0
Geschlecht
F
Eingang
15.06.2021
Impfdatum
15.06.2021
Beginn
15.06.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Headache Limb discomfort Nausea Tinnitus Vision blurred

Symptomtext

headace, dizziness, nauseated, ringing in ears, eye focus, "heavy" arms and legs

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1286537

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

mild
Staat
OR
Alter
63,0
Geschlecht
F
Eingang
04.05.2021
Impfdatum
20.04.2021
Beginn
04.05.2021
Tage bis Beginn
14,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Impaired work ability Injection site erythema Urticaria

Symptomtext

Developed a red welt over injection site hours after, and awoke next day with severe pain in joints, requiring early dismissal from her work and assistance. Joint pain lasted 1 day and welt lasted 3 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Bilat hip relacement, HTN, chronic pain
Andere Medikamente
cyclobenzaprine, lisinopril, hydrochlorothiazide, bupropion XL 300mg, hydrocodone/APAP 5/325mg
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 1196710

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9nh54

mild
Staat
SD
Alter
63,0
Geschlecht
M
Eingang
12.04.2021
Impfdatum
06.04.2021
Beginn
10.04.2021
Tage bis Beginn
4,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pruritus Rash Rash pruritic

Symptomtext

Itchiness and rash on left side of body. Rash went away after 2 days but itchiness continues for 5 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Lisinopril 10mg, hydrochlorothiazide 25mg
Allergien
Clarithromycin
Vorherige Impfungen
-

VAERS 1474384

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

gering
Staat
OR
Alter
62,0
Geschlecht
F
Eingang
15.07.2021
Impfdatum
05.06.2021
Beginn
06.06.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blister Lip blister

Symptomtext

Patient called 7/15/21 to report that she will not be getting the second dose due to experiencing blisters of the upper lip that spread to her nose. She spoke with her provider and was instructed to take Benadryl, which she said did help. The provider recommended against getting the second dose. The blistering has since resolved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blister
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
cyclobenzaprine, duloxetine, naproxen
Allergien
-
Vorherige Impfungen
-

VAERS 1445681

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

gering
Staat
-
Alter
65,0
Geschlecht
M
Eingang
03.07.2021
Impfdatum
16.09.2020
Beginn
16.09.2020
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Inappropriate schedule of product administration

Symptomtext

two doses had been given / 7Jun2018 / and 16Sep2020 /dose was given on 23Jun2021; two doses had been given / 7Jun2018 / and 16Sep2020; This case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number 9NH54, expiry date 14th October 2022) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 7th June 2018). On 23rd June 2021, the patient received the 3rd dose of Shingrix. On 16th September 2020, the patient received the 2nd dose of Shingrix. On 16th September 2020, not applicable after receiving Shingrix and unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. In June 2021, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered and drug dose administration interval too long were unknown. Additional details were provided as follows: The patient received 2nd dose late than the recommended time interval, which led to lengthening of vaccination schedule. The patient received 3rd dose of Shingrix , which led to extra dose administered. The reporter reviewed patient's vaccine history and noticed that two doses were already given. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1425793

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

gering
Staat
IA
Alter
73,0
Geschlecht
F
Eingang
25.06.2021
Impfdatum
06.04.2021
Beginn
06.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

1st dose of Shingrix on 11Sep2019 / 2nd dose on 06Apr2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number 9NH54, expiry date 14th October 2022) for prophylaxis. Previously administered products included Shingrix (1st dose received on 11th September 2019). On 6th April 2021, the patient received the 2nd dose of Shingrix. On 6th April 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown. Additional details were provided as follows: The reporter stated that, the patient received 2nd dose late than the recommended schedule which led to lenghtening of vaccination schedule. No symptoms reported. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1313956

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9NH54

gering
Staat
WI
Alter
70,0
Geschlecht
M
Eingang
13.05.2021
Impfdatum
06.05.2021
Beginn
06.05.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Accidental overdose Extra dose administered No adverse event Product administration error

Symptomtext

NO ADVERSE EVENT, JUST ERROR; GAVE PATIENT THIRD DOSE OF ZOSTER VACCINE, GAVE 1ST DOSE IN NOVEMBER, AND ANOTHER ENTITY GAVE 2ND DOSE INBETWEEN WITH OUT INFORMING US.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-